PhD in Bioprocess Chemistry: Therapeutic Nucleoside Editing
Listed on 2026-10-10
-
Research/Development
Research Scientist, Biotech Research, Biotechnology, Pharmaceutical Science/ Research
The University of Manchester’s School of Chemistry invites applications for a fully funded PhD studentship in Bioprocess:
Skeletal Editing of Therapeutic Nucleosides.
This 3.5-year programme starts in 2026 and focuses on developing bioprocess strategies and skeletal editing to create novel therapeutic nucleosides, integrating synthesis, analytics, and biocatalysis within a collaborative research environment.
This posting is for the PhD in Bioprocess Chemistry:
Therapeutic Nucleoside Editing role at RFCSR, based in Manchester, England, United Kingdom.
Step into the PhD in Bioprocess Chemistry:
Therapeutic Nucleoside Editing role at RFCSR in Manchester, England, United Kingdom and grow with us.
Please review the full job details above before applying.
If your experience matches this role, we encourage you to apply.
All applications are reviewed carefully by our team.
The position is based in Manchester, England, United Kingdom.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).